A patent currently prohibits any generic Byetta from being manufactured and sold. However, there are companies claiming to sell a "generic Byetta," but be advised that these medications are fake, substandard, and potentially dangerous. The earliest date that a generic version of Byetta could become available is in 2016, when Byetta's first patent expires.
Generic for Byetta: An OverviewByetta® (exenatide) is a prescription medication that has been licensed as a type 2 diabetes treatment. The drug is an incretin mimetic, which means that it mimics the actions of the incretin hormones in the body. As an incretin mimetic, Byetta increases insulin production in response to meals and decreases the amount of glucose (sugar) that the liver produces. Byetta also slows the emptying of food from the stomach, which decreases the amount of food that people eat.
Byetta is manufactured by Amylin Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic Byetta from being manufactured in the United States. Yet, if you search the Internet for "generic Byetta," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. There may be generic Byetta available from another country, but there is really no way of knowing if you are getting genuine Byetta or not. You should not buy any generic Byetta until there is an approved generic available.